ARCHIVE-Transform access to clinical trials and EAPs through patient-centric solutions

Boost the impact of your clinical trials and expanded access by making them more accessible to patients & physicians.


Our pharma partners

We are here to help

Your patient situation is unique, and we understand that.

we will guide them and their family through the process of finding and accessing clinical trials. Many of us have personal experience with serious illnesses, so we understand the desire to know about all possible options.

“Patients often feel like they are on their own, and that’s difficult, but Patient Navigators are here to help them,”— Angela Sarmiento Betancourt, MD, senior Patient Navigator.

this is what we do

we’ve helped 5000+ people get their life- saving treatment.

Explore our comprehensive set of tools and resources, designed to simplify the search for treatment options and streamline the referral process. From clinical trial matching to patient referral, we’ve got you covered.

Meeting patients where they are

We create tailored clinical trial awareness campaigns and have relationships with key physician networks and patient advocacy groups within our focus areas through our Medical Community team.

Syncing stakeholders

We connect all relevant parties in clinical trials, streamlining recruitment activities and support on one platform.

Ensuring high-quality referrals

Our medically trained Patient Navigators pre-screen patients and compliantly collect the relevant medical information to reduce site screening burden.

Adhering to the highest standards of data privacy & security

Our platform and solutions strictly adhere to GDPR regulations and meet ISO-27001 standards for data security and privacy.

Our platform

Discover how our comprehensive omni-stakeholder solution supports BioPharma organizations globally to meet clinical development goals.

benefit #1

Connectivity between stakeholders

We have a full range of awareness tools and can offer pre-screening solutions, supported by state-of-the-art technology. This allows for timely engagement of sites with patients and their physicians, and the continuous sharing of high-quality referrals to trial sites.

benefit #2

Intuitive platform for EAP management and RWD collection

Our platform enables expanded access processes, including the possibility for patients & physicians to upload application documents securely on the platform. Additionally, myTomorrows’ fit-for-purpose EDC can be tailored for specific use cases according to client needs.

benefit #3

Secure and compliant reporting features   

Our platform is fully ISO 27001-certified and GDPR-compliant, allowing for secure and compliant data exchange in clinical trial and expanded access settings. This approach streamlines patient-trial matching and, in select instances, also allows for compliant reporting on the clinical trial recruitment funnel.

Ready to Dive Deeper?

Curious to learn more? Explore our patient resources for in-depth insights into your treatment journey. We have FAQs, guides, and informative videos to guide you every step of the way.

discover more resources

still have questions?

reach out to us

frequently asked questions

we’re freely supercharging everyone with the tools, products, and education to look and act like a rockstar.we’re freely supercharging everyone.

1. Can myTomorrows support real-world data collection under an EAP?

myTomorrows has been a thought leader and front runner in generating evidence from real-world data, collected within an expanded access setting. Our dedicated real-world data team offers an integrated approach towards the strategy, collection and analysis of data in non-interventional settings under Expanded Access pathways. 

Check out some of the papers published with our support:

2. How can myTomorrows help with enrolling patients into clinical trials?

We can support our clients with a variety of strategic awareness tactics to identify patients and facilitate participation in clinical trials.

In addition, our commitment to our mission has enabled us to build an extensive network of physicians and patient advocacy groups to support patients and their physicians to learn more about all available clinical trials. This network plays an important role in assisting patients and their physicians by accessing comprehensive information about clinical trials and if available, other pre-approval options.

3. How do we ensure data privacy and protection on our platform and in our activities?

myTomorrows is committed to data privacy and data protection for all our stakeholders and are continuously working on improving our processes and products to reflect this commitment.  

Our patient-centric approach means that respect for the users’ data privacy is of utmost importance to us. In practice, this means that we ensure transparent data processing by clearly communicating the purposes and legal basis for collecting patients’ data. We use clear and concise consent requests for each step that involves medical information. We practice data minimization, and only aim to collect the information necessary to support individuals in their journey. 

In addition, our platform ensures data security through encryption and access control to prevent unauthorized access and data breaches. Our platform and all our digital solutions are ISO 27001-certified. We have regular audits and assessments to monitor our compliance with GDPR standards and continually improve our data protection practices. 

Any user of our services may exercise their rights under GDPR at any point by contacting us at as indicated in our Privacy Statement.

Do you have a question around data privacy, data processing, or data protection? Please reach out to 

4. How does myTomorrows collect real-world data?

myTomorrows has a fit-for-purpose EDC that can be tailored for specific use cases according to client needs. It is supported by our platform and is designed to increase physician participation.

Through a unique design and set-up, we are able to increase uptake of data collection, as well as guarantee certain data quality that is necessary to increase the utility of data gathered for regulatory and payor purposes.

Our approach allows for the collection of both prospective and retrospective data, and we offer support from a remote CRA and medical team for monitoring purposes.

5. How does myTomorrows ensure high quality patient referrals to trial sites?

myTomorrows can ensure a thorough pre-screening process for our clients’ trials, conducted by our medically trained patient navigators using the latest technology. We gather essential required information from patients, and where applicable their physicians, to build an accurate and compliant medical profile. Via our ISO-27001-certified platform, we share these pseudonymized profiles with trial sites, for them to directly assess the benefit of an on-site screening visit.

This streamlined process minimizes the burden on trial sites and time better spent during on-site screenings, ultimately improving efficiency of clinical trial recruitment processes.

6. How does myTomorrows support BioPharma companies?

We support BioPharma companies to make their clinical trials and expanded access programs more accessible.  

We offer BioPharma both clinical trial recruitment and expanded access program management services.

Learn more.

7. How does myTomorrows support expanded access programs?

We guide BioPharma companies through developing expanded access strategies up to full EAP execution and preparation for full commercial launch. We have experience in a wide range of expanded access use cases, across different regions and therapeutics areas: 

  • free-of-charge or paid-for  
  • single patient or cohort programs 
  • post-trial access 

Conducting expanded access programs on behalf of our clients is our core expertise. Our team of experts handles areas such as Regulatory, Quality, Site Management, Supply Chain, Real-World Data, and Pharmacovigilance. 

Learn more.

8. How does myTomorrows work with clinical trial sponsors?

We support pharmaceutical companies with their clinical trial recruitment activities. Where possible, we support with trial awareness strategies, patient pre-screening, and direct referrals to trial sites via our platform.

9. How may our services to patients and their physicians support enrollment into clinical trials?

At myTomorrows, our mission is to support patients and healthcare professionals in navigating the complex landscape of clinical trials. We offer them a range of free-of-charge services aligned with this purpose, emphasizing a patient-centric approach where the patient and their physician make informed decisions together. Our goal is to assist the entire ecosystem, benefiting all stakeholders involved. 

Our overall approach to patients and HCPs is designed to be agnostic and unbiased, ensuring we are aligned with their interests. We maintain this commitment through compliant and impartial processes, always placing the patient and physician at the forefront of decision-making. This reimagines how patients and HCPs can be referred to clinical trials more effectively. 

As a result of our commitment, we are in constant contact with a diverse array of patients across various focus areas, supporting them in their healthcare journey. This engagement often leads to improved enrollment in clinical trials for BioPharma companies.  

For our BioPharma clients, we can conduct pre-screening services for patient recruitment purposes. This process starts once a patient and their HCP choose an appropriate clinical trial, allowing us to then conduct detailed pre-screening for that specific trial. If we are not directly involved with a particular trial, we always assist patients by facilitating connections with the relevant trial sites, ensuring they have access to suitable trials for their unmet medical needs. 

10. I lost my login and/or password. How do I reset my password?

If you lose your login and/or password, please go to the login page and click ‘forgot your password?’. An email with a link will be sent to your email address. If you still incur difficulties, please contact us via

11. What disease areas does myTomorrows cover?

myTomorrows supports a wide range of therapeutic areas, offering patient recruitment solutions across various medical fields. Whether your clinical trial is focused on oncology, rare diseases, hematology, neurology, or any other therapeutic area, we have the expertise to assist in patient recruitment, pre-screening, and referrals to clinical trials.

12. What is the myTomorrows platform?

To support patients and their healthcare professionals discover and access all possible treatment options, myTomorrows developed the go-to platform for searching and accessing clinical trials and expanded access programs.

For patients & physicians, this includes time-saving tools and Patient Navigator support to search and identify clinical trials and expanded access programs, as well as a GDPR-compliant, ISO-27001 certified platform to upload and share medical information.

For trial sites, we provide high-quality patient referrals thanks to our pre-screening process. If requested and consented to by the patient, they will have access to the patient’s medical information, and if deemed potentially eligible, trial sites can directly get in touch with the patient to invite them to be screened further.

For BioPharma companies, we can offer visibility into their full patient recruitment funnel, from trial awareness to referral and outcomes of on-site screening visits. These insights help identify bottlenecks that can be addressed together.

In an expanded access setting, our platform enables end-to-end EAP facilitation and management. Additionally, myTomorrows’ fit-for-purpose EDC can be tailored for specific use cases according to client needs.

Our platform is fundamentally patient-centric, and therefore our data sharing procedures are subject to patient consent when it relates to their pseudonymized data.

13. What is the role of Patient Navigators at myTomorrows?

Our Patient Navigators are an essential point of contact for patients to understand and find clinical trials and if available, expanded access programs. 

They are a familiar contact for patients throughout their journey of choice; while they cannot give medical advice, Patient Navigators are trained to explain complex medical concepts to patients. We offer dependable, multilingual support to patients covering U.S. and European time zones. 

Learn more about our services to patients here.

14. What pharmacovigilance services does myTomorrows offer?

Our services range from complete global pharmacovigilance to individual services supporting companies’ existing infrastructure. Our experts collaborate across all areas of clinical development to meet specific company needs. 

Our services include: 

  • Case processing 
  • Global safety report submissions 
  • Aggregate safety report preparation 
  • Qualified person responsible for pharmacovigilance (QPPV) 
  • Global and local literature searching and assessment. 
  • PV consultancy 
  • Labeling (core safety information) support 
  • Regulatory authority assessment report responses 

15. What regulatory services does myTomorrows offer for EAP management?

Our regulatory experts have extensive experience in the pharmaceutical industry (small molecules, biologics, cell and gene therapies) in global markets.

With a strong regulatory team, we provide flexible, client-oriented, and comprehensive services related to EAP management, including:

  • Regulatory strategy consultancy
  • Regulatory and GMP – GDP advice
  • Expanded Access regulatory advice and execution
  • Interaction with regulatory agencies
  • Reimbursement strategy advice
  • Medical and regulatory writing

let us help you

Please enable JavaScript in your browser to complete this form.